6 Protein Tyrosine Kinase Inhibitors
- 1 January 1996
- book chapter
- Published by Elsevier
- Vol. 33, 233-329
- https://doi.org/10.1016/s0079-6468(08)70307-2
Abstract
No abstract availableThis publication has 216 references indexed in Scilit:
- Inhibition of Serum-Induced M-Phase Progression by a Tyrosine Kinase Inhibitor, ErbstatinBiochemical and Biophysical Research Communications, 1993
- Decreased sensitivity of aorta from hypertensive rats to vasorelaxation by tyrphostinLife Sciences, 1993
- Isoflavonoids, genistein, psi-tectorigenin, and orobol, increase cytoplasmic free calcium in isolated rat hepatocytesBiochemical and Biophysical Research Communications, 1992
- Effects of herbimycin A and various SH-reagents on p60v-src kinase activity invitroBiochemical and Biophysical Research Communications, 1990
- Inhibition of EGF-induced phospholipase C activation in A341 cells by erbstatin, a tyrosine kinase inhibitorBiochemical and Biophysical Research Communications, 1990
- A synthetic peptide corresponding to residues 137 to 157 of p60v-src inhibits tyrosine-specific protein kinasesBiochemical and Biophysical Research Communications, 1990
- Selective inhibition of tyrosine protein kinase by a synthetic multisubstrate analogBiochemical and Biophysical Research Communications, 1989
- Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitorBiochemical and Biophysical Research Communications, 1989
- Inhibition of tyrosine protein kinases by the antineoplastic agent adriamycinBiochemical and Biophysical Research Communications, 1989
- Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxycinnamamide derivativesBiochemical and Biophysical Research Communications, 1987